Rational Design of Spherical Nucleic Acids: Expanding Horizons for Precision Nucleic Acid Therapy
Rattachement africain : cn, us, kr, sg, in, hk. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Nucleic acid therapy has emerged as a core focus in modern biotherapy owing to its capability of regulating diseases by targeting specific genes. However, key challenges such as nucleic acid susceptibility to enzymatic degradation, low cellular uptake, and poor tissue targeting have severely hindered their clinical translation. Notably, spherical nucleic acids (SNAs), as unique nucleic-acid-based nanoplatforms, offer a compelling solution to these bottlenecks, largely stemming from their geometry-driven advantages. Their high-curvature spherical structure, characterized by a nanoparticle core densely decorated with radially oriented oligonucleotides, endows them with modular flexibility, strong physiological stability, and efficient intracellular accumulation. Given their strong potential in biomedicine, this review systematically summarizes recent advances in the rational design of SNAs and their applications in precision nucleic acid therapy. Moreover, we decipher SNA structure-function relationships in depth to guide rational design, especially highlighting intelligent SNA strategies that respond to diverse disease microenvironments for precise treatment. Additionally, we demonstrate the functional versatility and broad engineering potential of SNAs, underscoring their indispensable role in expanding treatment scenarios. More importantly, this review updates the current knowledge of SNA design and provides actionable guidance for translating more efficient precision nucleic acid therapeutics from basic research to clinical practice.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Rational Design of Spherical Nucleic Acids: Expanding Horizons for Precision Nucleic Acid Therapy
- Date Crossref
- 25/03/2026
- Éditeur
- American Chemical Society (ACS)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.